High-dose oral magnesium treatment of chronic, intractable erythromelalgia

Annals of Pharmacotherapy

Volumn 36, Issue 2, 2002, Pages 255-260

  Cohen, Jay S ^a  

^a NONE   (United States)

Author keywords

Erythromelalgia; Magnesium

Indexed keywords

CALCIUM ANTAGONIST; DILTIAZEM; MAGNESIUM SULFATE; NIFEDIPINE; PAPAVERINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIARRHEA; DRUG MEGADOSE; ERYTHROMELALGIA; FEMALE; HUMAN; HYPERTENSION; INTERNET; MALE; MIGRAINE; PAIN; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REMISSION; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0036159192     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A186     Document Type: Article

References (49)

1. Erythromelalgia
2. Erythromelalgia: New theories and new therapies
3. Natural history of erythromelalgia: Presentation and outcome in 168 patients
4. Temperature-associated vascular disorders: Raynaud's phenomenon and erythromelalgia
5. Erythromelalgia: A condition caused by microvascular arteriovenous shunting
6. Skin perfusion in patients with erythromelalgia
7. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia
8. Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia
9. Refractory idiopathic erythromelalgia
10. Nitroprusside treatment of erythromelalgia in an adolescent female
11. Continuous epidural infusion of bupivacaine and fentanyl for erythromelalgia in an adolescent
12. Cervical epidural infusion of morphine and bupivacaine in severe erythromelalgia
13. A case of primary erythromelalgia (erythermalgia) treated with neural blockade
14. A way to understand erythromelalgia
15. Lumbar sympathectomy
16. Endoscopic thoracic sympathectomy for primary erythromelalgia in the upper extremities
17. Nifedipine and erythromelalgia
18. Nifedipine and erythromelalgia
19. Painful edema, erythematous rash, and burning sensation due to nifedipine
20. Possible erythromelalgia-like syndrome associated with nifedipine in a patient with Raynaud's phenomenon
21. Magnesium. An update on physiological, clinical and analytical aspects
22. Ionized magnesium supplementation in critically ill patients: Comparing ionized and total magnesium
23. Magnesium deficiency: A cause of heterogeneous disease in humans
24. Magnesium: Nature's physiologic calcium blocker
25. Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon
26. Intravenous magnesium sulfate rapidly alleviates headaches of various types
27. Nebulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma: A clinical trial
28. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: A critical review of new data
29. Role of magnesium in the pathogenesis and treatment of migraines
30. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects
31. The role of magnesium in the prevention and control of hypertension
32. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled crossover study
33. Muscle cramps and magnesium deficiency: Case reports
34. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulfate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer
35. Relief of neuropathic pain with intravenous magnesium
36. Magnesium sulfate reduces intra- and postoperative analgesic requirements
37. Effects of cold pressor test on circulating atrial natriuretic peptide 99-126 (ANP) in patients with Raynaud's phenomenon and influence of treatment with magnesium sulphate and nifedipine
38. Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud's phenomenon
39. Magnesium oxide augmentation of verapamil maintenance therapy in mania
40. Magnesium deficiency in the pathogenesis of mitral valve prolapse
41. Oral magnesium successfully relieves premenstrual mood changes
42. 6 for the relief of anxiety-related premenstrual symptoms: A randomized, double-blind, crossover study
43. The use of magnesium sulphate infusions in the management of very severe tetanus
44. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: A pilot study
45. Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks
46. Application of urine magnesium/creatinine ratio as an indicator for insufficient magnesium intake
47. Unsuspected morbid hypermagnesemia in elderly patients